Tumoral Prostate Shows Different Expression Pattern of Somatostatin Receptor 2 (SSTR2) and Phosphotyrosine Phosphatase SHP-1 (PTPN6) According to Tumor Progression

<table>Immunohistochemical pattern of SHP-1 and SSTR2 on hyperplasic human prostate. The picture has shown the characteristic SHP-1 (a) and SSTR2 (b) immunostaining on benign prostate hyperplasia hyperplasic. The intensity was classified as “+++” for comparison with tumor glands.</table>

Advances in Urology

fig1

Figure 1

Figure 1: Tumoral Prostate Shows Different Expression Pattern of Somatostatin Receptor 2 (SSTR2) and Phosphotyrosine Phosphatase SHP-1 (PTPN6) According to Tumor Progression 

Figure 1 | Tumoral Prostate Shows Different Expression Pattern of Somatostatin Receptor 2 (SSTR2) and Phosphotyrosine Phosphatase SHP-1 (PTPN6) According to Tumor Progression 